دورية أكاديمية
أعرض في EDS

Clinical approach to vasoplegia in the transplant patient from the Pediatric Heart Transplant Society.

التفاصيل البيبلوغرافية
العنوان: Clinical approach to vasoplegia in the transplant patient from the Pediatric Heart Transplant Society.
المؤلفون: Desphpande SR; Department of Cardiology and Cardiovascular Surgery, Children's National Hospital, The George Washington University, Washington, DC, USA., Bearl DW; Department of Pediatric Cardiology, Monroe Carell Jr. Children's Hospital, Nashville, Tennessee, USA., Eghtesady P; Section of Pediatric Cardiothoracic Surgery, St Louis Children's Hospital and School of Medicine, Washington University, St Louis, Michigan, USA., Henderson HT; Pediatrics, Medical University of South Carolina, Charleston, South Carolina, USA., Auerbach S; Pediatrics, Division of Cardiology, University of Colorado, Denver Anschutz Medical Campus, Children's Hospital Colorado Aurora, Aurora, Colorado, USA., Jeewa A; Department of Cardiology, Hospital for Sick Children, Toronto, Ontario, Canada., Bansal N; Children's Hospital at Montefiore, Bronx, New York, USA., Amdani S; Cleveland Clinic Children's, Cleveland, Ohio, USA., Richmond ME; Division of Pediatric Cardiology, Department of Pediatrics, Columbia University College of Physician and Surgeons, Morgan Stanley Children's Hospital, New York, New York, USA., Sacks LD; Pediatric Cardiology, Stanford University School of Medicine, Palo Alto, California, USA., Shih R; Congenital Heart Center, Division of Pediatric Cardiology, University of Florida, Gainesville, Florida, USA., Townsend M; Cleveland Clinic Children's, Cleveland, Ohio, USA., Conway J; Stollery Children's Hospital, University of Alberta, Edmonton, Alberta, Canada.
المصدر: Pediatric transplantation [Pediatr Transplant] 2022 Dec; Vol. 26 (8), pp. e14392.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Munksgaard Country of Publication: Denmark NLM ID: 9802574 Publication Model: Print Cited Medium: Internet ISSN: 1399-3046 (Electronic) Linking ISSN: 13973142 NLM ISO Abbreviation: Pediatr Transplant Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Copenhagen ; Malden, MA : Munksgaard, c1997-
مواضيع طبية MeSH: Vasoplegia*/etiology , Heart Transplantation*, Humans ; Child ; Adult ; Retrospective Studies ; Risk Factors
مستخلص: This manuscript outlines a clinical approach to vasoplegia incorporating the current state of knowledge regarding vasoplegia in pediatric patients immediately post-transplant and to identify modifiable factors both pre- and post-transplant that may reduce post-operative morbidity, end-organ dysfunction, and mortality. Centers participating in the Pediatric Heart Transplant Society (PHTS) were asked to provide their internal protocols and rationale for vasoplegia management, and applicable adult and pediatric data were reviewed. The authors synthesized the above protocols and literature into the following description of clinical approaches to vasoplegia highlighting areas of both broad consensus and of significant practice variation.
(© 2022 Wiley Periodicals LLC.)
References: Chan JL, Kobashigawa JA, Aintablian TL, et al. Characterizing predictors and severity of vasoplegia syndrome after heart transplantation. Ann Thorac Surg. 2018;105:770-777.
Sacks LD, Hollander SA, Zhang Y, et al. Vasoplegia after pediatric cardiac transplantation in patients supported with a continuous flow ventricular assist device. J Thorac Cardiovasc Surg. 2019;157:2433-2440.
Byrne JG, Leacche M, Paul S, et al. Risk factors and outcomes for ‘vasoplegia syndrome’ following cardiac transplantation. Eur J Cardiothorac Surg. 2004;25:327-332.
Asleh R, Alnsasra H, Daly RC, et al. Predictors and clinical outcomes of vasoplegia in patients bridged to heart transplantation with continuous-flow left ventricular assist devices. J Am Heart Assoc. 2019;8:e013108.
Patarroyo M, Simbaqueba C, Shrestha K, et al. Pre-operative risk factors and clinical outcomes associated with vasoplegia in recipients of orthotopic heart transplantation in the contemporary era. J Heart Lung Transplant. 2012;31:282-287.
Raza FS, Lee AY, Jamil AK, et al. Relation of vasoplegia in the absence of primary graft dysfunction to mortality following cardiac transplantation. Am J Cardiol. 2018;122:1902-1908.
Pandya NR, Alphonso N, Tu Q, Venugopal P, Schlapbach LJ. Prolonged postoperative vasoplegia in pediatric patients on chronic angiotensin II blocker treatment. Front Cardiovasc Med. 2018;5:121.
Dayan V, Cal R, Giangrossi F. Risk factors for vasoplegia after cardiac surgery: a meta-analysis. Interact Cardiovasc Thorac Surg. 2019;28:838-844.
Chan JL, Kobashigawa JA, Aintablian TL, et al. Vasoplegia after heart transplantation: outcomes at 1 year. Interact Cardiovasc Thorac Surg. 2017;25:212-217.
Fischer GW, Levin MA. Vasoplegia during cardiac surgery: current concepts and management. Semin Thorac Cardiovasc Surg. 2010;22:140-144.
Omar S, Zedan A, Nugent K. Cardiac vasoplegia syndrome: pathophysiology, risk factors and treatment. Am J Med Sci. 2015;349:80-88.
Gamcrlidze MM, Intskirveli NA, Vardosanidze DK, Chikhladze KE, Goliadze LS, Ratiani LR. Vasoplegia in septic shock (review). Georgian Med News. 2015;239:56-62.
Burgdorff A-M, Bucher M, Schumann J. Vasoplegia in patients with sepsis and septic shock: pathways and mechanisms. J Int Med Res. 2018;46:1303-1310.
Gkisioti S, Mentzelopoulos SD. Vasogenic shock physiology. Open Access Emerg Med. 2011;3:1-6.
Wan S, Marchant A, DeSmet JM, et al. Human cytokine response to cardiac transplantation and coronary artery bypass grafting. J Thorac Cardiovasc Surg. 1996;111:469-477.
Bitterman Y, Hubara E, Hadash A, Ben-Ari J, Annich G, Eytan D. Methylene blue administration for distributive shock states in critically ill children. Isr Med Assoc J. 2020;22:404-408.
Anderson NM, Bond GY, Joffe AR, et al. The Western Canadian complex pediatric therapies program follow-up group. Post-operative fluid overload as a predictor of hospital and long-term outcomes in a pediatric heart transplant population. Pediat Transplant. 2021;25(e13897):e13897.
Chang AC, Atz AM, Wernovsky G, Burke RP, Wessel DL. Milrinone: systemic and pulmonary hemodynamic effects in neonates after cardiac surgery. Crit Care Med. 1995;23:1907-1914.
Lambden S, Creagh-Brown BC, Hunt J, Summers C, Forni LG. Definitions of pathophysiology of vasoplegic shock. Crit Care. 2018;22:174.
Jeon Y, Ryu JH, Lim YJ, et al. Comparative hemodynamic effects of vasopressin and norepinephrine after milrinone-induced hypotension in off-pump coronary artery bypass surgical patients. Eur J Cardiothorac Surg. 2006;29:952-956.
Del Castillo S, Shaddy RE, Kantor PF. Update on pediatric heart failure. Curr Opin Pediatr. 2019;31:598-603.
Rahiman S, Kowalski R, Kwok SY, et al. Milrinone acts as a vasodilator but not an inotrope in children after cardiac surgery - insights from wave intensity analysis. Crit Care Med. 2020;48:e1071-e1078.
Busse LW, Barker N, Petersen C. Vasoplegic syndrome following cardiothoracic surgery-review of pathophysiology and update of treatment options. Crit Care. 2020;24:36.
Dünser MW, Bouvet O, Knotzer H, et al. Vasopressin in cardiac surgery: a meta-analysis of randomized controlled trials. J Cardiothorac Vasc Anesth. 2018;32:2225-2232.
Egi M, Bellomo R, Langenberg C, et al. Selecting a vasopressor drug for vasoplegic shock after adult cardiac surgery: a systematic literature review. Ann Thorac Surg. 2007;83:715-723.
Buarracino F, Habicher M, Treskatsch S, et al. Vasopressor therapy in cardiac surgery - an experts' consensus statement. J Cardiothorac Vasc Anesth. 2012;35:1018-1029.
van Diepen S, Katz JN, Albert NM, et al. Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association. Circulation. 2017;136:e232-e268.
Menich BE, Miano TA, Patel GP, Hammond DA. Norepinephrine and vasopressin compared with norepinephrine and epinephrine in adults with septic shock. Ann Pharmacother. 2019;53:877-885.
Kofidis T, Strüber M, Wilhelmi M, et al. Reversal of severe vasoplegia with single-dose methylene blue after heart transplantation. J Thorac Cardiovasc Surg. 2001;122:823-824.
Habib AM, Elsherbeny AG, Almehizia RA. Methylene blue for vasoplegic syndrome postcardiac surgery. Indian J Crit Care Med. 2018;22:168-173.
Annane D, Renault A, Brun-Buisson C, et al. Hydrocortisone plus fludrocortisone for adults with septic shock. N Engl J Med. 2018;378:809-818.
Brierley J, Carcillo JA, Choong K, et al. Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine. Crit Care Med. 2009;37:666-688.
Marik PE, Varon J. Requirement of perioperative stress doses of corticosteroids: a systematic review of the literature. Arch Surg. 2008;143:1222-1226.
Varvarousi G, Stefaniotou A, Varvaroussis D, Xanthos T. Glucocorticoids as an emerging pharmacologic agent for cardiopulmonary resuscitation. Cardiovasc Drug Ther. 2014;28:477-488.
Annane D, Pastores SM, Rochwerg B, et al. Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (part 1): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017. Intensive Care Med. 2017;43:1751-1763.
Cios TJ, Havens B, Soleimani B, Roberts SM. Hydroxocobalamin treatment of refractory vasoplegia in patients with mechanical circulatory support. J Heart Lung Transplant. 2019;38:467-469.
Shapeton AD, Mahmood F, Ortoleva JP. Hydroxocobalamin for the treatment of vasoplegia: a review of current literature and considerations for use. J Cardiothorac Vasc Anesth. 2019;33:894-901.
Marik PE, Khangoora V, Rivera R, Hooper MH, Catravas J. Hydrocortisone, vitamin c, and thiamine for the treatment of severe sepsis and septic shock: a retrospective before-after study. Chest. 2017;151:1229-1238.
Portman MA, Slee A, Olson AK, et al. Triiodothyronine supplementation in infants and children undergoing cardiopulmonary bypass (TRICC): a multicenter placebo-controlled randomized trial: age analysis. Circulation. 2010;122:S224-S233.
Khanna A, English SW, Wang XS, et al. Angiotensin II for the treatment of vasodilatory shock. The N Eng J Med. 2017;377:419-430.
Bailey DM, Chima RS, Tidmarsh GF, Williams MD. Synthetic human angiotensin II in pediatric patients with vasodilatory shock: a report on two patients. Crit Care Explor. 2019;1:e0036.
فهرسة مساهمة: Keywords: pediatric heart transplant; post-operative; vasoplegia
تواريخ الأحداث: Date Created: 20221115 Date Completed: 20221116 Latest Revision: 20221122
رمز التحديث: 20231215
DOI: 10.1111/petr.14392
PMID: 36377326
قاعدة البيانات: MEDLINE
الوصف
تدمد:1399-3046
DOI:10.1111/petr.14392